# Tripe Versus Dual Antiretroviral Therapy in HIV-infected Patients With Virological Suppression (Tridual)

> **NCT03447873** · PHASE4 · COMPLETED · sponsor: **Hospitales Universitarios Virgen del Rocío** · enrollment: 153 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Continue with triple therapy
- **DRUG:** Switch to DTG + 3TC
- **DRUG:** Switch to DRV/cobicistat + 3TC

## Key facts

- **NCT ID:** NCT03447873
- **Lead sponsor:** Hospitales Universitarios Virgen del Rocío
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2020-09-15
- **Final completion:** 2021-02-03
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2021-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03447873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03447873, "Tripe Versus Dual Antiretroviral Therapy in HIV-infected Patients With Virological Suppression (Tridual)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03447873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*